Discover a New Perspective on Pharmacy!
Join us for a series of brief talks showcasing the clinicians and scientists advancing new standards of care and therapies for a healthier future.
Thank you for joining us!
Jason Karnes
Associate Professor
From Big Data to Precision Medicine: Predicting, Preventing, and Understanding Adverse Drug Reactions
The unprecedented availability of large-scale biological data has paved the way for discovery in precision health. Potentially transformative resources, such as the All of Us Research Program, now curate genomes, electronic health records, and survey data for hundreds of thousands of diverse participants.
With a focus on immune-mediated adverse drug reactions, Jason Karnes will describe how big data can be leveraged to inform our knowledge of genomic influences on drug response and to translate clinical interventions for improvement of patient care.
Travis Wheeler
Associate Professor
Accelerating Drug Discovery with Artificial Intelligence
Drugs treat, cure, or prevent disease by binding with proteins in our cells. These binding interactions require that molecules (drugs) meet specific shape, size, and surface feature requirements. Predicting the binding potential of a new drug is an extremely challenging problem in developing new treatments.
In this talk, Travis Wheeler will describe efforts to build computer software, powered by modern methods in artificial intelligence, that will accelerate the pace (and reduce the cost) of drug discovery.
PharmTech: Innovations Enhancing Patient-Centered Care
Beth Zerr will share how pharmacists are employing technology in their practice to provide patient-centered care.
From virtual synchronous and asynchronous clinical visits, using remote patient data to advance care, and leveraging technology as a tool to improve medication adherence, pharmacists are innovating and delivering care in new ways.
Beth Zerr
Assistant Clinical Professor
When Less is More: Deprescribing in Older Adults
Ashley Campbell will highlight medications that may be associated with adverse outcomes when used long-term and as patients age.
She will introduce updates to clinical practice guidelines for some of the most common deprescribing targets, including aspirin, proton pump inhibitors, and other medication classes, while sharing open-access resources that are available to both healthcare professionals and the public.
Ashley Campbell
Associate Clinical Professor
Christopher Penton
Researcher
Demystifying Drug Discovery: Moving Liquids and Finding Drugs
Drug Screening involves testing anywhere from thousands to millions of compounds to find new therapeutics. At the most fundamental level, drug screening relies on the ability to scale experiments down smaller and smaller to make this process faster and more affordable. In addition, individualized approaches are required to manage data and help guide the drug discovery process.
The Arizona Center for Drug Discovery has made significant progress in these areas over the past year. The ACDD has steadily improved its throughput, currently at 10,000 compounds tested per day, and is expanding its reach to more and more investigators on campus. Dr. Penton, head of High-Throughput Screening, will discuss fundamentals of drug discovery and how we are starting a new era at the University of Arizona.
Christopher Hulme
Professor
Academia to Industry: Shepherding New Drugs through the "Valley of Death"
Arizona Center for Drug Discovery Co-Director Christopher Hulme will highlight the bench to bedside drug discovery process for oral medications, discussing the strengths of academic drug discovery and introducing the commonly used term ‘valley of death’ where a drug hunter can see the promised land on the far side of the valley but lacks effective transport to get there.